Vice President, Medical Affairs – Hematology-Oncology
Core
Lead the Medical Affairs organization to support the transition of targeted protein degradation hematology-oncology programs from late-stage clinical development to commercialization.
Role type
Vice President, Medical Affairs (Hematology-Oncology)
Builds
Medical strategy, evidence generation, MSL organization, and scientific engagement for targeted protein degradation therapies
Domain
Biopharmaceuticals, Hematology-Oncology, Targeted Protein Degradation
Required skills
Medical Affairs leadership, oncology/hematology clinical expertise, evidence generation strategy, MSL organization management, scientific communication, regulatory compliance, cross-functional launch planning
Preferred skills
Experience with innovative therapeutic platforms, first-in-class mechanisms, building Medical Affairs in growth-stage biotech
Technologies
None stated
Responsibilities
Lead and scale the Medical Affairs function for late-stage and commercial readiness; Own the overall Medical Affairs strategy for the hematology-oncology portfolio; Lead development of the scientific platform and differentiated medical narrative; Partner with Clinical Development to shape late-stage medical strategy and data generation priorities; Develop and execute integrated medical plans across field medical, scientific communications, and evidence generation; Expand and lead a high-performing MSL organization; Lead external engagement with key experts, investigators, and cooperative groups; Direct publication and scientific communication strategy; Lead integrated evidence generation strategies including RWE and HEOR; Partner with Commercial and Market Access for launch readiness; Monitor the external hematology-oncology landscape and translate insights into strategy; Ensure compliance with legal, regulatory, and company standards; Provide medical leadership to executive governance discussions; Support global Medical Affairs planning and coordination
Seniority
Executive, Senior Leadership
